Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-23

Clinical Trial Update: Study of Ibuprofen Effects on Brain Function [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study evaluating ibuprofen effects on brain function in adults with major depressive disorder has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Laureate Institute for Brain Research, Inc. | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-02-23